Home > > North America And Global Pharmaceutical Contract Development and Manufacturing Market- Size, Share, Growth Rate, and Forecast
The North America Pharmaceutical Contract Development and Manufacturing market was valued at $39,740.8 Million in 2023, and is projected to reach $59,946.5 Million by 2030 growing at a CAGR of 6.10% from 2024 to 2030. Pharmaceutical Manufacturing Services segment is expected to be the highest contributor to this market, with $31,841.3 Million in 2023, and is anticipated to reach $47,406.7 by 2030, registering a CAGR of 5.90%. Drug Development Services segment is anticipated to reach $7,317.2 Million by 2030 with the highest CAGR of 7.86%. Pharmaceutical Manufacturing Services and Drug Development Services segments collectively expected to account for about 91.0% share of the North America Pharmaceutical Contract Development and Manufacturing market in 2023, with the former constituting around 80.1% share. Drug Development Services and Pharmaceutical Manufacturing Services segments are expected to witness significant growth rates at a CAGR of 7.86% and 5.90% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 91.0% in the overall North America Pharmaceutical Contract Development and Manufacturing market in 2023, and is anticipated to reach 91.3% by 2030. Service Pharmaceutical Manufacturing Services Biologics Manufacturing Services Drug Development Services End User Big Pharma Small & Mid-size Pharma Generic Pharmaceutical Companies Other End Users BY REGION North America US Canada Europe Germany France UK Italy Spain RoE Asia China Japan India RoAPAC Middle East & Africa Latin America MEA